Atlas Trials

Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management

Clinical trial NCT05561309 · UNKNOWN

Trial details

NCT number
NCT05561309
Sponsor
Shanghai Hengrui Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Total Knee Arthroplasty
Start date
2022-10-20
Primary completion
2024-12-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.